'Velcade, lenalidomide and dexamethasone combo show promise for multiple myelo... - The Diigo Meta page

• 13 Dec 07
  

  Sally Church

  New combinations are the way forward in the treatment of cancer - targeting different aspects of the cancer cell may help reduce resistance. For example, the Rev/Vel/Dex combo in myeloma looks very promising indeed.

  biotechnology biomarkers cancer cell health hematology innovation medicine new oncology myeloma

Would you like to comment?

Join Diigo for a free account, or sign in if you are already a member.